Author: Mark DeFrance

Mark DeFrance is a senior research analyst at Tech Insider, focusing on the enterprise software sector. Prior to joining TI, Mark covered enterprise software for First Albany, and prior to that he worked in equity research at B.T. Alex Brown and Bankers Trust. Mark has written software applications in various programming languages including BASIC, Pascal, and COBOL. He has also been recognized in The Wall Street Journal's "Best on the Street" survey and was recognized by Forbes Magazine as the No. 1 sell-side stock picker in the software industry for a five-year period, with returns of 115% versus 26% for the software industry.
BioTech

SolarWinds (NYSE:SWI) Price Target Increased by Jefferies

On Wednesday, Jefferies raised it’s price target for SolarWinds (NYSE:SWI) to $57 from $51.  In a research note issued by Aaron Schwartz, he indicated that the company’s cash flow potential remains underappreciated.  The stock continues to be a stock favorite at Jefferies. Highlights of the note included: 20% license growth could serve as a baseline. Stable ASPs with recent levels, and productivity from 2013 sales … Continue reading SolarWinds (NYSE:SWI) Price Target Increased by Jefferies

Mark DeFrance
Services Sector

Services Sector Active Stocks: Sirius XM Holdings (NASDAQ:SIRI), J.C. Penney (NYSE:JCP), E Commerce China Dangdang (NYSE:DANG), Comcast (NASDAQ:CMCSA)

Earlier last month, Sirius XM Holdings Inc’ majority owner Liberty Media Corp. (LMCA), which is controlled by media mogul John Malone, offered to buy around 48% of Sirius XM Holdings Inc. (SIRI) it does not already own in a deal that could be worth more than $10 billion. Sirius XM Holdings Inc. (NASDAQ:SIRI) stock performance was -1.11% in last session and finished the day at … Continue reading Services Sector Active Stocks: Sirius XM Holdings (NASDAQ:SIRI), J.C. Penney (NYSE:JCP), E Commerce China Dangdang (NYSE:DANG), Comcast (NASDAQ:CMCSA)

Mark DeFrance
BioTech

Biotech Gainers: Arrowhead Research (NASDAQ:ARWR), DARA Biosciences (NASDAQ:DARA), Synthetic Biologics (NYSEMKT:SYN), Oncothyreon (NASDAQ:ONTY)

Equities research analysts at Deutsche Bank assumed coverage on shares of Arrowhead Research Corp (NASDAQ:ARWR) in a research note issued to investors on Wednesday, TheFlyOnTheWall.com reports. The firm set a “buy” rating and a $45.00 price target on the stock. Arrowhead Research Corp (NASDAQ:ARWR) stock performance was 24.46% in last session and finished the day at $26.31. Traded volume was 7,684,553 million shares in the … Continue reading Biotech Gainers: Arrowhead Research (NASDAQ:ARWR), DARA Biosciences (NASDAQ:DARA), Synthetic Biologics (NYSEMKT:SYN), Oncothyreon (NASDAQ:ONTY)

Mark DeFrance
Services Sector

Services Sector Active Runners: SIRIUS XM Holding (NASDAQ:SIRI), Rite Aid (NYSE:RAD), Delta Air Lines (NYSE:DAL), American Airlines (NASDAQ:AAL)

Sirius XM Holding Inc (NASDAQ:SIRI) announced that Emmy award-winning actor, writer, and producer Seth MacFarlane will sit down for an intimate Q&A session with a select group of listeners for the SiriusXM “Town Hall” Series. SIRIUS XM Holding Inc (NASDAQ:SIRI) stock performance was 0.56% in last session and finished the day at $3.59. Traded volume was 46,800,394 million shares in the last session and the … Continue reading Services Sector Active Runners: SIRIUS XM Holding (NASDAQ:SIRI), Rite Aid (NYSE:RAD), Delta Air Lines (NYSE:DAL), American Airlines (NASDAQ:AAL)

Mark DeFrance
BioTech

Biotech Gainers: Insys Therapeutics Inc (NASDAQ:INSY), Oxygen Biotherapeutics (NASDAQ:OXBT), Halozyme Therapeutics (NASDAQ:HALO), Cytori Therapeutics (NASDAQ:CYTX)

Insys Therapeutics (NASDAQ:INSY) hit a new 52-week high during trading on Tuesday following a better than expected earnings announcement, AnalystRatings.NET reports. Insys Therapeutics Inc (NASDAQ:INSY) stock performance was 21.73% in last session and finished the day at $83.37. Traded volume was 1,203,992 million shares in the last session and the average volume of the stock remained 263.48 million shares. The beta of the stock remained … Continue reading Biotech Gainers: Insys Therapeutics Inc (NASDAQ:INSY), Oxygen Biotherapeutics (NASDAQ:OXBT), Halozyme Therapeutics (NASDAQ:HALO), Cytori Therapeutics (NASDAQ:CYTX)

Mark DeFrance
Services Sector

Services Sector Top Losers: Central European Media (NASDAQ:CETV), Darden Restaurants (NYSE:DRI), Zulily (NASDAQ:ZU), Denny’s Corporation (NASDAQ:DENN)

Central European Media Enterprises Ltd. (NASDAQ:CETV) shares jumped more than 92 percent in the last trading session before settling up almost 75 percent to $4.74. There were two reasons to explain the surge of the stock. First was that the company reported financial results which showed narrow loss compared to the same quarter of last year. Central European Media Enterprises Ltd. (NASDAQ:CETV) stock performance was … Continue reading Services Sector Top Losers: Central European Media (NASDAQ:CETV), Darden Restaurants (NYSE:DRI), Zulily (NASDAQ:ZU), Denny’s Corporation (NASDAQ:DENN)

Mark DeFrance